HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Inoue Selected Research

denopamine

7/2001Beta1-adrenoceptor stimulation by high-dose terbutaline downregulates terbutaline-stimulated alveolar fluid clearance in ex vivo rat lung.
2/2001Beta1-adrenergic agonist is a potent stimulator of alveolar fluid clearance in hyperoxic rat lungs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Inoue Research Topics

Disease

71Neoplasms (Cancer)
06/2020 - 01/2000
19Carcinogenesis
01/2017 - 01/2000
15Infections
02/2017 - 01/2000
12Neoplasm Metastasis (Metastasis)
12/2007 - 03/2000
11Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2004 - 02/2000
9Carcinoma (Carcinomatosis)
07/2010 - 02/2000
8Stomach Neoplasms (Stomach Cancer)
07/2010 - 02/2000
7Adenocarcinoma
09/2001 - 05/2000
7Atherosclerosis
09/2001 - 01/2000
6Hypoxia (Hypoxemia)
08/2015 - 07/2001
6Endometrial Neoplasms (Endometrial Cancer)
02/2015 - 06/2000
6Pain (Aches)
02/2012 - 02/2000
6Hepatocellular Carcinoma (Hepatoma)
01/2009 - 12/2000
6Esophageal Neoplasms (Esophageal Cancer)
06/2001 - 01/2000
5Hypertension (High Blood Pressure)
04/2001 - 05/2000
4Stroke (Strokes)
10/2017 - 09/2000
4Lung Neoplasms (Lung Cancer)
01/2017 - 03/2001
4Autoimmune Diseases (Autoimmune Disease)
05/2016 - 02/2010
4Type 2 Diabetes Mellitus (MODY)
11/2012 - 02/2000
4Hepatitis
12/2009 - 03/2001
4Neuroblastoma
02/2009 - 03/2000
4Body Weight (Weight, Body)
10/2007 - 03/2000
4Colorectal Neoplasms (Colorectal Cancer)
08/2007 - 03/2000
4Graft vs Host Disease (Graft-Versus-Host Disease)
03/2006 - 05/2000
4Heart Failure
03/2004 - 04/2000
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2003 - 01/2000
3Inflammation (Inflammations)
01/2018 - 09/2003
3Cardiovascular Diseases (Cardiovascular Disease)
01/2017 - 06/2007
3Prostatic Neoplasms (Prostate Cancer)
01/2017 - 01/2000
3Ischemia
07/2015 - 08/2001
3Reperfusion Injury
07/2015 - 01/2000
3Cysts
01/2014 - 12/2000
3Cognitive Dysfunction
04/2012 - 04/2007
3Thymoma (Thymic Carcinoma)
02/2012 - 07/2000
3Necrosis
08/2011 - 01/2001
3Myasthenia Gravis
12/2009 - 09/2006
3Chronic Hepatitis C
12/2009 - 09/2005
3Hyperalgesia
03/2008 - 06/2000
3Cystic Fibrosis (Mucoviscidosis)
12/2007 - 07/2007
3Gastroesophageal Reflux (GERD)
11/2006 - 12/2003
3Chromosome Aberrations (Chromosome Abnormalities)
09/2006 - 09/2001
3Epstein-Barr Virus Infections
12/2005 - 07/2000
3Arthritis (Polyarthritis)
03/2003 - 03/2000
3Leukemia
10/2002 - 10/2000
3Wounds and Injuries (Trauma)
04/2002 - 01/2001
3Hyperplasia
04/2002 - 09/2000
3Fibrosis (Cirrhosis)
10/2001 - 09/2000
3Adenoma (Adenomas)
05/2001 - 01/2000
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2001 - 11/2000

Drug/Important Bio-Agent (IBA)

15Messenger RNA (mRNA)IBA
01/2018 - 01/2000
15Proteins (Proteins, Gene)FDA Link
08/2014 - 01/2000
15Telomerase (Telomerase Reverse Transcriptase)IBA
03/2012 - 01/2000
10Biological ProductsIBA
01/2019 - 02/2000
6Biomarkers (Surrogate Marker)IBA
01/2018 - 02/2000
6AcidsIBA
01/2018 - 08/2001
6Pharmaceutical PreparationsIBA
05/2016 - 06/2001
6EnzymesIBA
03/2004 - 01/2000
5Interleukin-6 (Interleukin 6)IBA
05/2012 - 01/2000
5Estrogens (Estrogen)FDA Link
04/2012 - 10/2000
5Cisplatin (Platino)FDA LinkGeneric
01/2010 - 07/2000
5Gallic AcidIBA
11/2001 - 10/2000
4AntioxidantsIBA
10/2017 - 08/2000
4Retinaldehyde (Retinal)IBA
12/2015 - 01/2001
4CytokinesIBA
10/2014 - 01/2000
4Peptides (Polypeptides)IBA
01/2011 - 05/2000
4Oxygen (Dioxygen)IBA
11/2007 - 01/2001
4Glucose (Dextrose)FDA LinkGeneric
02/2007 - 09/2000
4Cadherins (E-Cadherin)IBA
03/2001 - 02/2000
3VitaminsIBA
10/2017 - 11/2001
3Ascorbic Acid (Vitamin C)FDA LinkGeneric
10/2017 - 08/2000
3Vitamin DFDA LinkGeneric
01/2017 - 08/2007
3ErbB Receptors (EGF Receptor)IBA
01/2017 - 09/2010
3Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
05/2016 - 04/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2016 - 04/2000
3Green Fluorescent ProteinsIBA
04/2015 - 05/2000
3Transcription Factors (Transcription Factor)IBA
04/2015 - 05/2000
3Therapeutic UsesIBA
09/2012 - 10/2000
3CalciumIBA
12/2009 - 03/2000
3Alanine Transaminase (SGPT)IBA
12/2009 - 08/2001
3Matrix Metalloproteinases (MMPs)IBA
03/2009 - 03/2000
3Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2007 - 05/2000
3Transforming Growth Factor beta1 (TGF beta 1)IBA
07/2006 - 05/2001
3DNA (Deoxyribonucleic Acid)IBA
05/2006 - 04/2000
3Mitochondrial DNA (mtDNA)IBA
09/2005 - 03/2001
3Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
12/2004 - 03/2000
3Superoxide DismutaseIBA
06/2004 - 05/2000
3Monomeric GTP-Binding ProteinsIBA
03/2001 - 05/2000
3LDL Lipoproteins (beta Lipoproteins)IBA
02/2001 - 08/2000
3Glutathione (Reduced Glutathione)IBA
01/2001 - 05/2000
3Cyclin D1IBA
12/2000 - 02/2000
3beta CateninIBA
08/2000 - 03/2000

Therapy/Procedure

30Therapeutics
04/2015 - 01/2000
11Drug Therapy (Chemotherapy)
08/2014 - 07/2000
10Transplantation
12/2017 - 05/2000
6Lung Transplantation
07/2015 - 05/2012
5Radiotherapy
11/2007 - 12/2000
5Bone Marrow Transplantation (Transplantation, Bone Marrow)
03/2006 - 04/2000
4Hematopoietic Stem Cell Transplantation
10/2015 - 06/2001
3Oral Administration
08/2014 - 10/2001
3Lymph Node Excision (Lymph Node Dissection)
01/2007 - 01/2000